Efficacy and Safety Study of ZOMETA in Treatment of High-Level NTX Non Small Cell Lung Cancer With Bone Metastasis.
Phase of Trial: Phase IV
Latest Information Update: 09 Dec 2013
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Bone metastases; Non-small cell lung cancer
- Focus Therapeutic Use
- 03 Feb 2012 Planned end date changed from 1 Aug 2011 to 1 Aug 2012 as reported by ClinicalTrials.gov.
- 03 Feb 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 23 May 2011 Planned End Date changed from 1 Sep 2010 to 1 Aug 2011 as reported by ClinicalTrials.gov.